-
Investors Watch List: Synthetic Biologics Inc. (NYSEMKT:SYN), National Oilwell Varco (NYSE:NOV), Alcoa Inc. (NYSE:AA), ARM Holdings (NASDAQ:ARMH), Orion Energy Systems (NYSEMKT:OESX)
On Tuesday shares of Synthetic Biologics Inc. (NYSEMKT:SYN) closed at $2.45. Synthetic Biologics Inc. (NYSEMKT:SYN) reported financial results for the year ended December 31, 2014, General and administrative expenses were $6.0 million for the year ended December 31, 2014, compared to $5.8 million for the same period in 2013. National Oilwell Varco, Inc. (NYSE:NOV) in…
-
5 Stocks: Synthetic Biologics Inc. (NYSEMKT:SYN), Banco Santander, S.A. (NYSE:SAN), Porter Bancorp Inc. (NASDAQ:PBIB), McEwen Mining Inc. (NYSE:MUX), General Electric Company (NYSE:GE)
Synthetic Biologics Inc. (NYSEMKT:SYN) announced that preclinical results supporting the development of SYN-004, the Company’s candidate therapy designed to degrade intravenous (IV) antibiotics within the gastrointestinal (GI) tract and maintain the natural balance of the gut microbiome for the prevention of C. difficileinfection, will be presented during Digestive Disease Week® (DDW) 2015 in Washington DC…
-
Stocks Getting Investor’s Attention: Landmark Infrastructure Partners LP (NASDAQ:LMRK), Synthetic Biologics Inc. (NYSEMKT:SYN), Dejour Energy (NYSEMKT:DEJ), Celgene (NASDAQ:CELG), Fusion Telecommunications International (NASDAQ:FSNN)
On March 4, Landmark Infrastructure Partners LP (NASDAQ:LMRK) announced that it has acquired 81 tenant sites located in 21 states from its sponsor, Landmark Dividend LLC (“Landmark”), for total consideration of $25.2 million. The acquisition is expected to be immediately accretive to the Partnership’s distributable cash flow, and the Partnership’s management expects to recommend that…
-
Investors Should Watch: Synthetic Biologics Inc. (NYSEMKT:SYN), Pixelworks (NASDAQ:PXLW), Intel Corporation (NASDAQ:INTC), RLI Corp. (NYSE:RLI), Interactive Brokers Group (NASDAQ:IBKR)
Synthetic Biologics, Inc. (NYSEMKT:SYN) that the Company intends to release its financial results for the year ended December 31, 2014 on Monday, March 16, 2015 . On Friday shares of Synthetic Biologics Inc. (NYSEMKT:SYN) closed at $2.45. Pixelworks, Inc. (NASDAQ:PXLW) announced that Bruce Walicek, President and Chief Executive Officer, and Steven Moore, Chief Financial Officer,…
-
Traders Are Gambling on: Fastenal Company (NASDAQ:FAST), Synthetic Biologics Inc. (NYSEMKT:SYN), The Dow Chemical (NYSE:DOW), Unum Group (NYSE:UNM), PT Telekomunikasi Indonesia (NYSE:TLK)
It was reported on 25 February 2015, that Fastenal Company (NASDAQ:FAST) had $3.8 billion in sales in 22 countries in 2014. It hasn’t used the Export-Import Bank, but the company sent its chief financial officer and vice president of national sales to Washington to back the bank because two of its biggest customers — Westinghouse…
-
5 Stocks in Dramatic Moves: VIVUS Inc. (NASDAQ:VVUS), Synthetic Biologics Inc. (NYSEMKT:SYN), 1347 Property Insurance (NASDAQ:PIH), LightPath Technologies (NASDAQ:LPTH), General Motors (NYSE:GM)
VIVUS Inc. (NASDAQ:VVUS) on February 24, 2015, reported a loss of $25.4 million in its fourth quarter. The Mountain View, California-based company said it had a loss of 25 cents per share. The results did not meet Wall Street expectations. The average estimate of analysts surveyed by Zacks Investment Research was for a loss of…
-
Don’t Miss These Stocks: Amphastar Pharmaceuticals (NASDAQ:AMPH), Synthetic Biologics Inc. (NYSEMKT:SYN), BP p.l.c. (NYSE:BP), Stifel Financial (NYSE:SFN), Integrys Energy Group (NYSE:TEG)
On February 20, it was reported that, Ohio Attorney General Mike DeWine recently asked Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) to provide rebates to government agencies that purchased the drug naloxone after the company allegedly hiked its prices for the heroin overdose drug. Agencies such as police departments and fire departments distribute the drug to people who…
-
Investor’s Choice: Microsoft Corporation (NASDAQ:MSFT), Genetic Technologies Limited (NASDAQ:GENE), Baidu Inc (ADR) (NASDAQ:BIDU), Synthetic Biologics Inc. (NYSEMKT:SYN), Las Vegas Sands Corp. (NYSE:LVS)
Microsoft Corporation (NASDAQ:MSFT) says its Windows Defender anti-virus software can remove Lenovo’s Superfish bug from PCs. Concerned users should update to the newest version of Windows Defender, followed by a virus scan as soon as possible. On Friday shares of Microsoft Corporation (NASDAQ:MSFT) closed at $43.85. Company’s sales growth for last 5 years was 8.20%…
-
Stocks Getting Investors Attention: Xueda Education (NYSE:XUE), Synthetic Biologics Inc. (NYSEMKT:SYN), Delta Air Lines (NYSE:DAL), Regeneron Pharmaceuticals (NASDAQ:REGN), Royal Caribbean Cruises (NYSE:RCL)
Xueda Education Group (NYSE:XUE) announced that it will release its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2014, after the U.S. market closes on March 4, 2015. On Thursday shares of Xueda Education Group (NYSE:XUE) closed at $2.69. Company’s sales growth for last 5 years was 59.00% On 10…
-
Biotech Big Gainers: Synthetic Biologics Inc. (NYSEMKT:SYN), Amicus Therapeutics (NASDAQ:FOLD), Sangamo Biosciences Inc. (NASDAQ:SGMO), Idera Pharmaceuticals (NASDAQ:IDRA), Pfenex Inc. (NYSEMKT:PFNX)
Synthetic Biologics, Inc. (NYSEMKT:SYN) announced positive top-line results from a randomized, double-blind, placebo-controlled phase Ib study on its investigational oral beta-lactamase enzyme, SYN-004. On Wednesday shares of Synthetic Biologics Inc. (NYSEMKT:SYN) closed at $1.86. Amicus Therapeutics (NASDAQ:FOLD), highlighted results from preclinical studies of its next-generation Pompe ERT at WORLD Symposium™ 2015 in Orlando, Florida. Amicus…